Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.45B |
| 2 |
Visa
V
|
+$1.05B |
| 3 |
Microsoft
MSFT
|
+$1.01B |
| 4 |
Apple
AAPL
|
+$578M |
| 5 |
Norfolk Southern
NSC
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.24B |
| 2 |
McDonald's
MCD
|
+$707M |
| 3 |
JPMorgan Chase
JPM
|
+$680M |
| 4 |
Texas Instruments
TXN
|
+$678M |
| 5 |
Edwards Lifesciences
EW
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.8% |
| 2 | Healthcare | 2.66% |
| 3 | Financials | 2.38% |
| 4 | Consumer Discretionary | 2.05% |
| 5 | Industrials | 2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11776
Champions Oncology
CSBR
$73.6M
| $106K | ﹤0.01% |
+16,326
| New | +$115K |
|
|
CVAC
11777
PUT
DELISTED
CureVac
CVAC
| $106K | ﹤0.01% |
19,600
-67,800
| -78% | -$367K |
|
11778
CALL
Vir Biotechnology
VIR
$1.54B
| $106K | ﹤0.01% |
18,500
-2,100
| -10% | -$10.7K |
|
11779
Gabelli Equity Trust
GAB
$1.78B
| $105K | ﹤0.01% |
17,298
-8,377
| -33% | -$50.3K |
|
|
MVO
11780
DELISTED
MV Oil Trust
MVO
| $105K | ﹤0.01% |
+18,740
| New | +$110K |
|
11781
PUT
SELLAS Life Sciences
SLS
$2.33B
| $105K | ﹤0.01% |
65,400
+32,400
| +98% | +$57.7K |
|
11782
First Guaranty Bancshares
FGBI
$155M
| $105K | ﹤0.01% |
13,126
-93
| -0.7% | -$777 |
|
11783
CALL
ALX Oncology
ALXO
$258M
| $105K | ﹤0.01% |
57,500
+3,700
| +7% | +$3.2K |
|
|
SDHIU
11784
Siddhi Acquisition Corp Unit
SDHIU
$211M
| $105K | ﹤0.01% |
+10,199
| New | +$105K |
|
|
QTEX
11785
QTREX Quantum
QTEX
$60.2M
| $105K | ﹤0.01% |
+82,567
| New | +$104K |
|
|
OCFT
11786
CALL
DELISTED
OneConnect Financial Technology
OCFT
| $105K | ﹤0.01% |
13,800
+200
| +1% | +$1.47K |
|
11787
PUT
Nurix Therapeutics
NRIX
$2.61B
| $104K | ﹤0.01% |
11,300
| – | – |
|
11788
PUT
inTEST
INTT
$179M
| $104K | ﹤0.01% |
13,300
+1,400
| +12% | +$10.3K |
|
|
VMEO
11789
PUT
DELISTED
Vimeo
VMEO
| $104K | ﹤0.01% |
13,400
-1,700
| -11% | -$8.37K |
|
11790
Cellectar Biosciences
CLRB
$20.1M
| $104K | ﹤0.01% |
+18,526
| New | +$91.8K |
|
11791
PUT
1-800-Flowers.com
FLWS
$265M
| $104K | ﹤0.01% |
+22,500
| New | +$124K |
|
|
PHD
11792
DELISTED
Pioneer Floating Rate Fund
PHD
| $103K | ﹤0.01% |
+10,373
| New | +$103K |
|
11793
PUT
Spero Therapeutics
SPRO
$73M
| $103K | ﹤0.01% |
54,800
-82,400
| -60% | -$181K |
|
11794
Copel
ELPC
$8.6B
| $103K | ﹤0.01% |
11,467
-6,089
| -35% | -$50.4K |
|
11795
Horizon Technology Finance
HRZN
$294M
| $103K | ﹤0.01% |
+16,841
| New | +$122K |
|
|
PDM
11796
CALL
Piedmont Realty Trust
PDM
$1.21B
| $103K | ﹤0.01% |
11,400
-5,300
| -32% | -$42.6K |
|
11797
MoneyHero
MNY
$41M
| $103K | ﹤0.01% |
+71,732
| New | +$121K |
|
11798
Journey Medical
DERM
$176M
| $102K | ﹤0.01% |
+14,390
| New | +$104K |
|
11799
CALL
Cadiz
CDZI
$273M
| $102K | ﹤0.01% |
21,700
-32,200
| -60% | -$112K |
|
11800
CALL
Ovid Therapeutics
OVID
$489M
| $102K | ﹤0.01% |
78,500
+62,900
| +403% | +$54.5K |
|
Similar funds
Citadel Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Citadel Advisors held 14,587 positions worth $657B, up 14% from $576B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors's Q3 2025 filing shows 2,292 new, 5,365 increased, 4,887 reduced and 1,963 closed positions. Its largest new stake was Permian Resources: 18,381,735 shares worth $235M. The largest sale was Hess, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q3 2025 buy was Permian Resources: 18,381,735 shares worth $235M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q3 2025, an estimated $1.45B increase.
- Citadel Advisors's biggest Q3 2025 reduction was McDonald's, cutting an estimated $707M.
- Citadel Advisors fully exited Hess in Q3 2025, selling an estimated $1.24B.
- Citadel Advisors's ten largest holdings make up 25% of its $657B portfolio in Q3 2025.
- Citadel Advisors opened 2,292 new positions and closed 1,963 in Q3 2025.
- Citadel Advisors's portfolio value rose 14% quarter-over-quarter to $657B.
Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.